Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

Prognosis of multiple sclerosis is highly variable. Clinical variables have been identified that are assessable early in the disease and are predictors of the time from the disease onset to the onset of irreversible disability. Our objective was to determine if these clinical variables still have an effect after the first stages of disability have been reached. We determined the dates of disease onset and assignment of scores of irreversible disability in 1844 patients with multiple sclerosis. We used three scores on the Kurtzke Disability Status Scale as benchmarks of disability accumulation: 4 (limited walking but without aid); 6 (walking with unilateral aid); and 7 (wheelchair bound). We used Kaplan-Meier analyses and Cox regression models to determine the influence of the clinical variables on the time to disability onset. Median times from onset of multiple sclerosis to assignment of a score of 4, 6 and 7 were significantly influenced by gender, age, symptoms and course (relapsing-remitting or progressive) at onset of the disease, degree of recovery from the first relapse, time to a second neurological episode, and the number of relapses in the first 5 years of the disease. Similarly, times from onset of multiple sclerosis to a score of 6 and 7 were influenced by time to a score of 4. In contrast, none of the variables substantially affected the time from a score of 4 to a score of 6 or 7, or from a score of 6 to a score of 7. Early assessable clinical variables significantly influence the time from the onset of multiple sclerosis to the assignment of a disability score of 4, but not the subsequent progression of irreversible disability.

[1]  P. Thygesen Prognosis in initial stage of disseminated primary demyelinating disease of central nervous system. , 1949, Archives of neurology and psychiatry.

[2]  R. Grelland Perforation of the infracted interventricular septum diagnosed ante mortem. , 2009, Acta medica Scandinavica.

[3]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[4]  D. Mcalpine The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. , 1961, Brain : a journal of neurology.

[5]  K. Hyllested LETHALITY, DURATION, AND MORTALITY OF DISSEMINATED SCLEROSIS IN DENMARK , 1961, Acta psychiatrica Scandinavica.

[6]  F. Mcdowell,et al.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS , 1965, Annals of the New York Academy of Sciences.

[7]  T. Fog,et al.  The course of multiple sclerosis in 73 cases with computer-designed curves. , 1970, Acta neurologica Scandinavica. Supplementum.

[8]  U. Leibowitz,et al.  Multiple Sclerosis: Clues to Its Cause , 1973 .

[9]  S. Poser,et al.  CLINICAL DATA FROM 418 MS PATIENTS IN RELATION TO THE DIAGNOSIS. FIRST EXPERIENCES WITH AN OPTICAL MARK READER DOCUMENTATION SYSTEM , 1973, Acta neurologica Scandinavica.

[10]  G. Beebe,et al.  Studies on the natural history of multiple sclerosis--8. Early prognostic features of the later course of the illness. , 1977, Journal of chronic diseases.

[11]  O. Vuia THE BENIGN FORM OF MULTIPLE SCLEROSIS , 1977 .

[12]  G. Aimard,et al.  Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. , 1980, Brain : a journal of neurology.

[13]  V. Clark,et al.  Factors associated with a malignant or benign course of multiple sclerosis. , 1982, JAMA.

[14]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[15]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[16]  K. Lauer,et al.  Prognostic indicators in multiple sclerosis , 1986, Acta neurologica Scandinavica.

[17]  A. Alpérovitch,et al.  [South-Eastern France, a high risk area for multiple sclerosis?]. , 1987, Presse medicale.

[18]  J. G. Phadke Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[19]  G. Ebers,et al.  NATURAL HISTORY OF MULTIPLE SCLEROSIS , 2001, Journal of neurology, neurosurgery, and psychiatry.

[20]  A. Prange,et al.  Course and prognosis of chronic progressive multiple sclerosis: Results of an epidemiological study , 1988, Acta neurologica Scandinavica.

[21]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. , 1989, Brain : a journal of neurology.

[22]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.

[23]  J. G. Phadke Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis. , 1990, Brain : a journal of neurology.

[24]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. , 1991, Brain : a journal of neurology.

[25]  C Confavreux,et al.  EDMUS, a European database for multiple sclerosis. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[26]  K. Lauer,et al.  Early prognostic factors for disability in multiple sclerosis, a European multicenter study , 1992, Acta neurologica Scandinavica.

[27]  O. Andersen,et al.  Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. , 1993, Brain : a journal of neurology.

[28]  A. Sadovnick,et al.  Epidemiology of Multiple Sclerosis: A Critical Overview , 1993, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[29]  T. Riise,et al.  Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[30]  G. Serio,et al.  Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[31]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[32]  R. Kinkel,et al.  Management of multiple sclerosis. , 1997, The New England journal of medicine.

[33]  O. Kantarci,et al.  Survival and predictors of disability in Turkish MS patients , 1998, Neurology.

[34]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. , 1999, Brain : a journal of neurology.

[35]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.

[36]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.

[37]  R. Rudick,et al.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS , 1999, Neurology.

[38]  H. Adams,et al.  Progressive cerebral atrophy in MS: A serial study using registered, volumetric MRI , 2000, Neurology.

[39]  Hristian,et al.  RELAPSES AND PROGRESSION OF DISABILITY IN MULTIPLE SCLEROSIS , 2000 .

[40]  Christian Confavreux,et al.  Natural history of multiple sclerosis: implications for counselling and therapy , 2002, Current opinion in neurology.

[41]  Alastair Compston,et al.  McAlpine's Multiple Sclerosis , 2005 .